Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Nutralife Biosciences Inc (PK:NLBS)

Business Focus: Pharmaceuticals

Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEC
Company Contact
Address: 6601 Lyons Rd
COCONUT CREEK FL 33073-3627
Tel: N/A
Website: https://nutralifebiosciences.com
IR: See website
Key People
Edgar Ward
President, Chief Executive Officer, Director
Neil Catania
Vice President
 
Business Overview
NutraLife BioSciences, Inc. is engaged in the development and distribution of nutritional and dietary oral spray products. The Company is a producer and distributor of nutritional supplements that uses micro molecular formulae and the utilization of an oral spray to provide efficient absorption. Its products are sold to private label distributors who sell the products it manufactures under their own brand name. The Company manufactures and distributes oral spray nutritional and dietary products. Its distribution strategy includes selling to private label customers retailers, distributors, and consumers through retail outlets. Its wholly owned subsidiaries include Precision Analytic Testing, LLC, NutraDerma Technologies, Inc., PhytoChem Technologies, Inc., and TransDermalRX, Inc.
Financial Overview
For the nine months ended 30 September 2022, Nutralife Biosciences Inc revenues increased 2% to $251K. Net loss decreased 37% to $3.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Stock-based compensation decrease of 84% to $391K (expense), Other income (expense) increase from $3K to $55K (income), Income from sublease increase of 11% to $55K (income).